2020
DOI: 10.3390/cancers12051210
|View full text |Cite
|
Sign up to set email alerts
|

Advantages of Using Paclitaxel in Combination with Oncolytic Adenovirus Utilizing RNA Destabilization Mechanism

Abstract: Oncolytic virotherapy is a novel approach to cancer therapy. Ad-fosARE is a conditionally replicative adenovirus engineered by inserting AU-rich elements (ARE) in the 3’-untranslated region of the E1A gene. In this study, we examined the oncolytic activity of Ad-fosARE and used it in a synergistic combination with the chemotherapeutic agent paclitaxel (PTX) for treating cancer cells. The expression of E1A was high in cancer cells due to stabilized E1A-ARE mRNA. As a result, the efficiency of its replication an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 46 publications
0
7
0
Order By: Relevance
“…Microtubule networks are important for adenovirus entry, nuclear tracking, and the development of replication 37 . PTX is also known to affect the instability of microtubules by acetylation and detyrosination, which is essential for viral internalization and trafficking to the nucleus 38 . Recent papers reported the efficacy of the combination of OAd with PTX 38,39 .…”
Section: Discussionmentioning
confidence: 99%
“…Microtubule networks are important for adenovirus entry, nuclear tracking, and the development of replication 37 . PTX is also known to affect the instability of microtubules by acetylation and detyrosination, which is essential for viral internalization and trafficking to the nucleus 38 . Recent papers reported the efficacy of the combination of OAd with PTX 38,39 .…”
Section: Discussionmentioning
confidence: 99%
“…Triple combination of chemotherapy, ICB therapy, and OVT has been applied in the clinic because synergistic efficacy has been reported between OVs and some chemical agents such as gemcitabine and paclitaxel [ 140 , 141 ]. Recently, this triple combination strategy was applied in a phase Ib trial treating patients with unresectable PDAC.…”
Section: Ovs In Combination With Immunotherapymentioning
confidence: 99%
“…A growing list of conventional chemotherapy regimens, including gemcitabine, infusional fluorouracil, leucovorin, and oxaliplatin, paclitaxel, and cisplatin are being investigated as combination therapy with a variety of OVs. [20][21][22][23] Radiation therapy. Another modality of interest for combination treatment with OVs is external beam radiotherapy (XRT).…”
Section: Combination Therapymentioning
confidence: 99%